カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

豚流行性脳炎不活化ワクチンのグローバル市場2023：マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン

■ 英語タイトル：Global Swine Epidemic Encephalitis Inactivated Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11589）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11589
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[豚流行性脳炎不活化ワクチンのグローバル市場2023：マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、豚流行性脳炎不活化ワクチンのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の豚流行性脳炎不活化ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 豚流行性脳炎不活化ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

豚流行性脳炎不活化ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン

用途別セグメント
・子豚、成豚

主要な市場プレーヤー
・KM Biologics、Zoetis Animal Health、Boehringer-Ingelheim、Eurovet、Hipra、China Animal Husbandry Industry、Inyu Bio-technology、TECON、SPAH、Chongqing Auleon Biologicals、Wuhan Keqian Biology、Hunan Sinoland Bio-Pharmaceutical、MERRY、Shanghai Hile Bio-Technology、Guangdong Winsun Bio Pharmaceutical、Jinhe Biotechnology

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、豚流行性脳炎不活化ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚流行性脳炎不活化ワクチンメーカーの企業概要、2019年～2022年までの豚流行性脳炎不活化ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚流行性脳炎不活化ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別豚流行性脳炎不活化ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの豚流行性脳炎不活化ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での豚流行性脳炎不活化ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および豚流行性脳炎不活化ワクチンの産業チェーンを掲載しています。
・第14、15章では、豚流行性脳炎不活化ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 豚流行性脳炎不活化ワクチンの概要
– 種類別分析（2018年vs2022年vs2029年）：マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン
– 用途別分析（2018年vs2022年vs2029年）：子豚、成豚
– 世界の豚流行性脳炎不活化ワクチン市場規模・予測
– 世界の豚流行性脳炎不活化ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– KM Biologics、Zoetis Animal Health、Boehringer-Ingelheim、Eurovet、Hipra、China Animal Husbandry Industry、Inyu Bio-technology、TECON、SPAH、Chongqing Auleon Biologicals、Wuhan Keqian Biology、Hunan Sinoland Bio-Pharmaceutical、MERRY、Shanghai Hile Bio-Technology、Guangdong Winsun Bio Pharmaceutical、Jinhe Biotechnology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン
・用途別分析2018年-2029年：子豚、成豚
・豚流行性脳炎不活化ワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚流行性脳炎不活化ワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚流行性脳炎不活化ワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚流行性脳炎不活化ワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・豚流行性脳炎不活化ワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Swine Epidemic Encephalitis Inactivated Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Mouse Brain Inactivated Vaccine
1.3.3 Cell Culture Inactivated Vaccine
1.3.4 Cell Culture Live Attenuated Vaccine
1.3.5 Genetically Engineered Live Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size & Forecast
1.5.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (2018-2029)
1.5.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 KM Biologics
2.1.1 KM Biologics Details
2.1.2 KM Biologics Major Business
2.1.3 KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.1.4 KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 KM Biologics Recent Developments/Updates
2.2 Zoetis Animal Health
2.2.1 Zoetis Animal Health Details
2.2.2 Zoetis Animal Health Major Business
2.2.3 Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.2.4 Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Animal Health Recent Developments/Updates
2.3 Boehringer-Ingelheim
2.3.1 Boehringer-Ingelheim Details
2.3.2 Boehringer-Ingelheim Major Business
2.3.3 Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.3.4 Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer-Ingelheim Recent Developments/Updates
2.4 Eurovet
2.4.1 Eurovet Details
2.4.2 Eurovet Major Business
2.4.3 Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.4.4 Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurovet Recent Developments/Updates
2.5 Hipra
2.5.1 Hipra Details
2.5.2 Hipra Major Business
2.5.3 Hipra Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.5.4 Hipra Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hipra Recent Developments/Updates
2.6 China Animal Husbandry Industry
2.6.1 China Animal Husbandry Industry Details
2.6.2 China Animal Husbandry Industry Major Business
2.6.3 China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.6.4 China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 China Animal Husbandry Industry Recent Developments/Updates
2.7 Inyu Bio-technology
2.7.1 Inyu Bio-technology Details
2.7.2 Inyu Bio-technology Major Business
2.7.3 Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.7.4 Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Inyu Bio-technology Recent Developments/Updates
2.8 TECON
2.8.1 TECON Details
2.8.2 TECON Major Business
2.8.3 TECON Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.8.4 TECON Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 TECON Recent Developments/Updates
2.9 SPAH
2.9.1 SPAH Details
2.9.2 SPAH Major Business
2.9.3 SPAH Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.9.4 SPAH Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 SPAH Recent Developments/Updates
2.10 Chongqing Auleon Biologicals
2.10.1 Chongqing Auleon Biologicals Details
2.10.2 Chongqing Auleon Biologicals Major Business
2.10.3 Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.10.4 Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chongqing Auleon Biologicals Recent Developments/Updates
2.11 Wuhan Keqian Biology
2.11.1 Wuhan Keqian Biology Details
2.11.2 Wuhan Keqian Biology Major Business
2.11.3 Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.11.4 Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wuhan Keqian Biology Recent Developments/Updates
2.12 Hunan Sinoland Bio-Pharmaceutical
2.12.1 Hunan Sinoland Bio-Pharmaceutical Details
2.12.2 Hunan Sinoland Bio-Pharmaceutical Major Business
2.12.3 Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.12.4 Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hunan Sinoland Bio-Pharmaceutical Recent Developments/Updates
2.13 MERRY
2.13.1 MERRY Details
2.13.2 MERRY Major Business
2.13.3 MERRY Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.13.4 MERRY Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 MERRY Recent Developments/Updates
2.14 Shanghai Hile Bio-Technology
2.14.1 Shanghai Hile Bio-Technology Details
2.14.2 Shanghai Hile Bio-Technology Major Business
2.14.3 Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.14.4 Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shanghai Hile Bio-Technology Recent Developments/Updates
2.15 Guangdong Winsun Bio Pharmaceutical
2.15.1 Guangdong Winsun Bio Pharmaceutical Details
2.15.2 Guangdong Winsun Bio Pharmaceutical Major Business
2.15.3 Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.15.4 Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
2.16 Jinhe Biotechnology
2.16.1 Jinhe Biotechnology Details
2.16.2 Jinhe Biotechnology Major Business
2.16.3 Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
2.16.4 Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Jinhe Biotechnology Recent Developments/Updates
3 Competitive Environment: Swine Epidemic Encephalitis Inactivated Vaccine by Manufacturer
3.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Swine Epidemic Encephalitis Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Swine Epidemic Encephalitis Inactivated Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Swine Epidemic Encephalitis Inactivated Vaccine Manufacturer Market Share in 2022
3.5 Swine Epidemic Encephalitis Inactivated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Epidemic Encephalitis Inactivated Vaccine Market: Region Footprint
3.5.2 Swine Epidemic Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
3.5.3 Swine Epidemic Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Region
4.1.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Region (2018-2029)
4.2 North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029)
4.3 Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029)
4.5 South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type (2018-2029)
5.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application (2018-2029)
6.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Country
7.3.1 North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Country
8.3.1 Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Country
10.3.1 South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Swine Epidemic Encephalitis Inactivated Vaccine Market Drivers
12.2 Swine Epidemic Encephalitis Inactivated Vaccine Market Restraints
12.3 Swine Epidemic Encephalitis Inactivated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Swine Epidemic Encephalitis Inactivated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Epidemic Encephalitis Inactivated Vaccine
13.3 Swine Epidemic Encephalitis Inactivated Vaccine Production Process
13.4 Swine Epidemic Encephalitis Inactivated Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Epidemic Encephalitis Inactivated Vaccine Typical Distributors
14.3 Swine Epidemic Encephalitis Inactivated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 4. KM Biologics Major Business
Table 5. KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 6. KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. KM Biologics Recent Developments/Updates
Table 8. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 9. Zoetis Animal Health Major Business
Table 10. Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 11. Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Zoetis Animal Health Recent Developments/Updates
Table 13. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer-Ingelheim Major Business
Table 15. Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 16. Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer-Ingelheim Recent Developments/Updates
Table 18. Eurovet Basic Information, Manufacturing Base and Competitors
Table 19. Eurovet Major Business
Table 20. Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 21. Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Eurovet Recent Developments/Updates
Table 23. Hipra Basic Information, Manufacturing Base and Competitors
Table 24. Hipra Major Business
Table 25. Hipra Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 26. Hipra Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hipra Recent Developments/Updates
Table 28. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 29. China Animal Husbandry Industry Major Business
Table 30. China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 31. China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. China Animal Husbandry Industry Recent Developments/Updates
Table 33. Inyu Bio-technology Basic Information, Manufacturing Base and Competitors
Table 34. Inyu Bio-technology Major Business
Table 35. Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 36. Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Inyu Bio-technology Recent Developments/Updates
Table 38. TECON Basic Information, Manufacturing Base and Competitors
Table 39. TECON Major Business
Table 40. TECON Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 41. TECON Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. TECON Recent Developments/Updates
Table 43. SPAH Basic Information, Manufacturing Base and Competitors
Table 44. SPAH Major Business
Table 45. SPAH Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 46. SPAH Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. SPAH Recent Developments/Updates
Table 48. Chongqing Auleon Biologicals Basic Information, Manufacturing Base and Competitors
Table 49. Chongqing Auleon Biologicals Major Business
Table 50. Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 51. Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chongqing Auleon Biologicals Recent Developments/Updates
Table 53. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 54. Wuhan Keqian Biology Major Business
Table 55. Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 56. Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wuhan Keqian Biology Recent Developments/Updates
Table 58. Hunan Sinoland Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Hunan Sinoland Bio-Pharmaceutical Major Business
Table 60. Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 61. Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hunan Sinoland Bio-Pharmaceutical Recent Developments/Updates
Table 63. MERRY Basic Information, Manufacturing Base and Competitors
Table 64. MERRY Major Business
Table 65. MERRY Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 66. MERRY Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. MERRY Recent Developments/Updates
Table 68. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 69. Shanghai Hile Bio-Technology Major Business
Table 70. Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 71. Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 73. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Guangdong Winsun Bio Pharmaceutical Major Business
Table 75. Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 76. Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 78. Jinhe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 79. Jinhe Biotechnology Major Business
Table 80. Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Product and Services
Table 81. Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Jinhe Biotechnology Recent Developments/Updates
Table 83. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 84. Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 86. Market Position of Manufacturers in Swine Epidemic Encephalitis Inactivated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Swine Epidemic Encephalitis Inactivated Vaccine Production Site of Key Manufacturer
Table 88. Swine Epidemic Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
Table 89. Swine Epidemic Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
Table 90. Swine Epidemic Encephalitis Inactivated Vaccine New Market Entrants and Barriers to Market Entry
Table 91. Swine Epidemic Encephalitis Inactivated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 93. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 94. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 97. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 98. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 99. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 100. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 103. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 104. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 109. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 110. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 111. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 112. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 113. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 114. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 115. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 116. North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 119. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 120. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 121. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 122. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 123. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 124. Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 127. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 128. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 129. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 130. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 131. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 132. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 135. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 136. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 137. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 138. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 139. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 140. South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 143. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 144. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 145. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 146. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 147. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 148. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Swine Epidemic Encephalitis Inactivated Vaccine Raw Material
Table 151. Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine Raw Materials
Table 152. Swine Epidemic Encephalitis Inactivated Vaccine Typical Distributors
Table 153. Swine Epidemic Encephalitis Inactivated Vaccine Typical Customers
List of Figures
Figure 1. Swine Epidemic Encephalitis Inactivated Vaccine Picture
Figure 2. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Mouse Brain Inactivated Vaccine Examples
Figure 5. Cell Culture Inactivated Vaccine Examples
Figure 6. Cell Culture Live Attenuated Vaccine Examples
Figure 7. Genetically Engineered Live Attenuated Vaccine Examples
Figure 8. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Piglets Examples
Figure 11. Adults Pigs Examples
Figure 12. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 15. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 16. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Swine Epidemic Encephalitis Inactivated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Swine Epidemic Encephalitis Inactivated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Swine Epidemic Encephalitis Inactivated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 31. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Swine Epidemic Encephalitis Inactivated Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 34. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Swine Epidemic Encephalitis Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Swine Epidemic Encephalitis Inactivated Vaccine Market Drivers
Figure 75. Swine Epidemic Encephalitis Inactivated Vaccine Market Restraints
Figure 76. Swine Epidemic Encephalitis Inactivated Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Swine Epidemic Encephalitis Inactivated Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Swine Epidemic Encephalitis Inactivated Vaccine
Figure 80. Swine Epidemic Encephalitis Inactivated Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source

※参考情報

豚流行性脳炎不活化ワクチンは、豚のウイルス感染症を予防するために開発されたワクチンです。このワクチンは、豚流行性脳炎（Swine Epidemic Encephalitis、以下SE）は、特に繁殖豚や子豚に対して致命的な影響を与える可能性があるウイルス性感染症に関連しています。流行性脳炎は、豚の集団に広がって大規模な経済的損失を引き起こすことがありますので、その予防は非常に重要です。

まず、豚流行性脳炎の定義から説明します。この病気は、豚の中枢神経系に感染し、重篤な神経症状を引き起こします。このウイルスは豚に高い致死率をもたらし、感染した個体は行動異常、震え、昏睡などの症状を示します。さらには、この病気は豚の生産性にも大きく影響を与えます。健康な豚と感染した豚との接触を防ぐことが、発生を抑えるためには重要です。

不活化ワクチンの特徴について話しましょう。豚流行性脳炎不活化ワクチンは、ウイルスを不活化して作成されており、これによりワクチンが接種された豚が免疫応答を引き起こすことが可能になります。この種のワクチンは、感染力を持たないため、実際の病気を引き起こすリスクが少ないという利点があります。また、ワクチン接種後に得られる免疫は、病原体に対する特異的な抗体を生成し、将来の感染から豚を守ることができるようになります。

一般的に、不活化ワクチンは、即効性があるわけではなく、接種後に数週間を要して免疫が形成されます。そのため、豚の管理者は、特に流行が疑われる時期に前もって接種を行うことが必要です。このワクチンは、一般的には1回または複数回の接種が必要であり、接種スケジュールは獣医師や飼養管理者の指導に基づいて決定されます。

次に、豚流行性脳炎不活化ワクチンの種類について見ていきます。このワクチンにはいくつかの異なる製品が存在し、それぞれが異なるウイルス株に基づいて開発されています。マーケットには、さまざまなメーカーからの製品があり、各製品はその製造プロセスや不活化方法、添加物の有無などによって異なります。主に豚の健康状態や地域のウイルス流行状況に応じて、適切な製品を選択することが求められます。

ここで注目すべきは、ワクチンの用途です。主要な用途は、豚の疾病予防として特に強調されます。農場単位での感染を防ぐため、飼育初期段階でのワクチン接種が推奨されるほか、特定のリスクの高い時期や状況下でも接種が行われます。また、豚の集団飼育において感染の拡大を防ぐための重要な手段とされています。

さらに、豚流行性脳炎不活化ワクチンの関連技術についても触れておきます。ワクチンの開発と製造には、様々な技術が使用されます。例えば、ウイルスを不活化するために用いられる方法としては、化学薬品の使用や高温処理などがあります。これらの技術は、ウイルスの病原性を消失させつつ、免疫原性は保持するように設計されています。

また、最近の技術の進展により、アジュバントの添加が行われることが一般的になっています。アジュバントは、ワクチンの免疫反応を強化する役割を果たします。これにより、ワクチンの効果を高め、必要な接種回数を減らすことが期待されています。

結論として、豚流行性脳炎不活化ワクチンは、豚の健康を維持し、経済的損失を防ぐための重要な手段であると言えます。感染症の管理において、ワクチン接種は動物福祉にも寄与します。飼養者や獣医師は、地域の流行状況や豚の健康状態に応じて、最適なワクチン接種計画を立てる必要があります。感染症に対する対策とともに、持続可能な豚の飼育に貢献することが期待されます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンのグローバル市場2023：生ワクチン、不活化ワクチン
  • 豚マイコプラズマ・ハイオニューモニエ不活化ワクチンのグローバル市場2023：点鼻薬、胸部注射、筋肉注射、肺内注射
  • 世界の弱毒生日本脳炎ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 日本脳炎ウイルスワクチンの世界市場2025年：不活化ワクチン、弱毒生ワクチン
  • 豚連鎖球菌ワクチンのグローバル市場2023：生ワクチン、不活化ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11589 )"豚流行性脳炎不活化ワクチンのグローバル市場2023：マウス脳不活化ワクチン、細胞培養不活化ワクチン、細胞培養弱毒化生ワクチン、遺伝子組換え弱毒化生ワクチン" (英文：Global Swine Epidemic Encephalitis Inactivated Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。